KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Non-Current Debt (2016 - 2025)

Labcorp Holdings' Non-Current Debt history spans 17 years, with the latest figure at $5.1 billion for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 4.63% year-over-year to $5.1 billion; the TTM value through Dec 2025 reached $5.1 billion, down 4.63%, while the annual FY2025 figure was $5.1 billion, 4.63% down from the prior year.
  • Non-Current Debt for Q4 2025 was $5.1 billion at Labcorp Holdings, roughly flat from $5.1 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $5.6 billion in Q1 2025 and bottomed at $3.0 billion in Q2 2024.
  • The 5-year median for Non-Current Debt is $5.1 billion (2025), against an average of $4.9 billion.
  • The largest annual shift saw Non-Current Debt crashed 39.68% in 2024 before it skyrocketed 82.72% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $5.4 billion in 2021, then fell by 6.97% to $5.0 billion in 2022, then decreased by 19.53% to $4.1 billion in 2023, then surged by 31.48% to $5.3 billion in 2024, then decreased by 4.63% to $5.1 billion in 2025.
  • Per Business Quant, the three most recent readings for LH's Non-Current Debt are $5.1 billion (Q4 2025), $5.1 billion (Q3 2025), and $5.1 billion (Q2 2025).